“Retraction Notice: Aceclofenac Tablet Formulation Study Using Nanosuspension as Granulating Agent”

https://pubmed.ncbi.nlm.nih.gov/38115987

This abstract is a retraction notice for a previous study published in 2020 that investigated the formulation of Aceclofenac tablets using nanosuspension as a granulating agent to enhance dissolution rate and oral bioavailability.